These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37173579)

  • 41. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
    Durongpisitkul K; Sangtawesin C; Khongphatthanayopthin A; Panamonta M; Sopontammarak S; Sittiwangkul R; Pongpanich B
    Asian Pac J Allergy Immunol; 2006 Mar; 24(1):27-32. PubMed ID: 16913186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Predictive value of serum ferritin and a new predictive model for intravenous immunoglobulin resistance in Kawasaki disease].
    Zhang YJ; Bai HT; Chen PL
    Zhonghua Er Ke Za Zhi; 2021 Dec; 59(12):1080-1085. PubMed ID: 34856668
    [No Abstract]   [Full Text] [Related]  

  • 44. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
    Lu Y; Chen T; Wen Y; Si F; Wu X; Yang Y
    BMC Pediatr; 2021 Sep; 21(1):406. PubMed ID: 34530763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
    Joung J; Oh JS; Yoon JM; Ko KO; Yoo GH; Cheon EJ
    BMC Pediatr; 2022 Aug; 22(1):474. PubMed ID: 35931986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of IVIG resistance predictive models in Kawasaki disease.
    Kaya Akca U; Arslanoglu Aydin E; Aykan HH; Serin O; Sag E; Demir S; Atalay E; Kasap M; Batu ED; Karagoz T; Bilginer Y; Ozen S
    Pediatr Res; 2022 Feb; 91(3):621-626. PubMed ID: 33753891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 48. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Four Scoring Systems in Predicting Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease in a Children's Hospital in Beijing, North China.
    Song R; Yao W; Li X
    J Pediatr; 2017 May; 184():120-124. PubMed ID: 28043682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vital Signs as Predictor Factors of Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease.
    Gámez-González LB; Hamada H; Cisneros Castolo M; Honda T; Yasukawa K; Takanashi JI
    Clin Pediatr (Phila); 2018 Sep; 57(10):1148-1153. PubMed ID: 29486579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
    Li SY; Ding Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
    Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
    Kanai T; Takeshita S; Kawamura Y; Kinoshita K; Nakatani K; Iwashima S; Takizawa Y; Hirono K; Mori K; Yoshida Y; Nonoyama S
    Heart Vessels; 2020 Oct; 35(10):1463-1472. PubMed ID: 32449049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
    Tanaka A; Inoue M; Hoshina T; Koga H
    J Pediatr; 2021 Sep; 236():95-100. PubMed ID: 34019881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A simple scoring model based on machine learning predicts intravenous immunoglobulin resistance in Kawasaki disease.
    Sunaga Y; Watanabe A; Katsumata N; Toda T; Yoshizawa M; Kono Y; Hasebe Y; Koizumi K; Hoshiai M; Kawakami E; Inukai T
    Clin Rheumatol; 2023 May; 42(5):1351-1361. PubMed ID: 36627530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
    Takeshita S; Kanai T; Kawamura Y; Yoshida Y; Nonoyama S
    PLoS One; 2017; 12(5):e0176957. PubMed ID: 28542183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
    Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome.
    Rigante D; Andreozzi L; Fastiggi M; Bracci B; Natale MF; Esposito S
    Int J Mol Sci; 2016 Feb; 17(3):278. PubMed ID: 26927060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.